BlackRock Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$2.18M Buy
144,713
+179
+0.1% +$2.7K ﹤0.01% 2162
2016
Q3
$2.2M Sell
144,534
-54,121
-27% -$825K ﹤0.01% 2076
2016
Q2
$7.71M Buy
198,655
+31,060
+19% +$1.21M 0.01% 1123
2016
Q1
$4.66M Buy
167,595
+11,454
+7% +$318K 0.01% 1426
2015
Q4
$8.4M Buy
156,141
+10,502
+7% +$565K 0.01% 1051
2015
Q3
$5.83M Buy
145,639
+25,037
+21% +$1M 0.01% 1270
2015
Q2
$3.85M Sell
120,602
-5,719
-5% -$183K ﹤0.01% 1707
2015
Q1
$3.02M Buy
126,321
+16,931
+15% +$404K ﹤0.01% 1741
2014
Q4
$1.93M Sell
109,390
-565
-0.5% -$9.97K ﹤0.01% 2063
2014
Q3
$1.51M Buy
109,955
+1,047
+1% +$14.4K ﹤0.01% 2207
2014
Q2
$1.84M Buy
+108,908
New +$1.84M ﹤0.01% 2133